DNA neither cares nor knows. DNA just is. And we dance to its music - Richard Dawkins
...I am skeptical that genomics will have much impact on improving human health. An immediate objection to this skepticism would be that genomic-driven advances have simply not had enough time to work their way into tangible treatments. It has only been 15 years since the first human genome was published. Fair enough. But the obvious follow-on question is, how much time is enough time?
I’d say that 15 years is more than enough time for a truly powerful advance to make an impact. Consider these examples:
- Germ theory as a cause of infectious disease was formulated in the mid-1870s. The first scientific vaccines were developed in the 1880s.
- Blood types were…
Genomics is not a pseudoscience or a hoax. It is an immensely important discipline that has yielded many insights about the human condition and will continue to do so. But putting it to use is far harder than many of its enthusiasts have led the public to believe.
The principal aim of BioNews is to provide accurate, balanced and timely news and comment on genetics, assisted conception, embryo/stem cell research and related areas.
Genetic Engineering & Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, from bench to business, was introduced in 1981 as the first biotechnology trade publication.
The Genome News Network (GNN) produces a lively and trusted online magazine that covers important developments in genomics research around the world. Our news coverage focuses on stories about genomics and human medicine, as well as the ways in which scientists are using genomics to find biological solutions to energy needs and environmental problems.
The objective of this site is to be a one stop location where one can find most of the freely available internet resources related to genomics and bioinformatics.
GeneCards is a searchable, integrated, database of human genes that provides concise genomic related information, on all known and predicted human genes.
The organization works to transform leadership in the genetics community to build capacity in advocacy organizations and to educate policymakers by leveraging the voices of individuals and families.
Genome British Columbia is a research organization that invests in and manages large-scale genomics and proteomics research projects and science and technology platforms focused on areas of strategic importance such as human health, forestry, fisheries, ethics, agriculture, and the environment.
Everyone using GCAT chips is a faculty member working with undergraduates and trying to bring genomics into the curriculum to help students.
The Genome in a Bottle Consortium is a public-private-academic consortium hosted by NIST to develop the technical infrastructure (reference standards, reference methods, and reference data) to enable translation of whole human genome sequencing to clinical practice.
In partnership with Genome Canada Industry Canada and the Province of Alberta, Genome Alberta was established in the fall of 2005 to focus on genomics as one of the central components of the Life Sciences Initiative in Alberta, and to help position the Initiative as a core research effort.
GenomeNet is a Japanese network of database and computational services for genome research and related research areas in biomedical sciences, operated by the Kyoto University Bioinformatics Center.
GenomeWeb’s editorial mission is to serve readers with exclusive, in-depth coverage of the technology, institutions, and scientists that make up the worldwide research enterprise of molecular biology.
Essentials of Medical Genomics fills this need, providing a concise, clearly written guide to the state of the art in genomic research, and explaining in easy-to-follow terms how it is changing the way patients are diagnosed and treated.
The Human Genome Organisation (HUGO) is the international organisation of scientists involved in human genetic and genomic research. Established in 1989 by a collection of the world's leading human geneticists, the primary ethos of the Human Genome Organisation is to promote and sustain international collaboration in the field of human genetics.
A challenge facing researchers today is that of piecing together and analyzing the plethora of data currently being generated through the Human Genome Project and scores of smaller projects. NCBI's Web site serves an an integrated, one-stop, genomic information infrastructure for biomedical researchers from around the world so that they may use these data in their research efforts.
The Society aims to foster discovery and characterization of genomic variations including population distribution and phenotypic associations.
The Human Proteome Organisation (HUPO) is an international scientific organization representing and promoting proteomics through international cooperation and collaborations by fostering the development of new technologies, techniques and training.
An international organisation dedicated to advanced research and training in molecular biology and biotechnology, with special regard to the needs of the developing world.
The International Genomics Consortium (IGC) is a non-profit medical research organization established to expand upon the discoveries of the Human Genome Project and other systematic sequencing efforts by combining world-class genomic research, bioinformatics and diagnostic technologies in the fight against cancer and other complex diseases.
A non-profit research institution dedicated to improving human health, nutrition and the environment.
At NHGRI, we are focused on advances in genomics research. Building on our leadership role in the initial sequencing of the human genome, we collaborate with the world's scientific and medical communities to enhance genomic technologies that accelerate breakthroughs and improve lives. By empowering and expanding the field of genomics, we can benefit all of humankind.
Zenome is a decentralized market of genomic data and services.
The American Society of Gene & Cell Therapy is a non-profit medical, scientific, and professional organization devoted to the research and development of therapies that involve the introduction of genetic material and/or cells into the body to treat or prevent disease.
APS aims to promote and facilitate proteomics research in the Australasian region, by organising and managing conferences, instructional courses and workshops.
For more than two decades Dr. J. Craig Venter and his research teams have been pioneers in genomic research.
Patients are at the core of everything we do. Alnylam was founded to help people who lack adequate treatment options live fuller, healthier lives. Their needs drive our discoveries, and their stories further our commitment to delivering innovative therapies.
Avesthagen was founded as a grid of verticals of biodiversity and horizontals of “omics” platforms. It has grown into an internationally recognized pioneer by using systems-biology to facilitate Scientific Discovery & Technology Development, with the aim of delivering innovative products and technologies for Healthcare, Wellness and Agriculture.
is a global market leader and an innovator in providing customer-centric molecular pathology solutions and complete walk-away automation of cell and tissue staining.
Cellectis is the worldwide leader in the research, development and commercialization of rational genome engineering technologies. Cellectis proprietary technologies and platform are based upon a naturally occurring class of DNA endonucleases, the Meganucleases and DNA recombination.
Editas Medicine is building the leading genome editing company dedicated to treating patients with genetically defined diseases.
Cancer is detected too late. At Exact Sciences, we’re committed to using our proven expertise and determination to change lives by detecting cancer earlier. We deliver life-changing innovations to give people the confidence to make more effective decisions. That’s our promise.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Genetic Technologies is a leader in the development and commercialisation of genetic risk assessment technology.
GenWay Biotech is a leading protein and antibody solutions provider. Our company strives to provide the best value of reagents to the research community. We stand by the data provided in our product datasheets, and we will offer full refunds if products do not meet the established specifications.
IntegraGen is dedicated to gene discovery and the commercialization of molecular diagnostics products and services that provide clinicians with new tools to personalize diagnosis, treatment, and therapy.
Invitae is a leader in advanced medical genetics. Our company was founded with a singular mission: to make genetic information affordable and accessible to everyone who can benefit from it. The Invitae team includes pioneers in genetics, medicine, technology, and genetic counseling, and is trusted by experts to provide the most comprehensive, reliable genetic screening and support available.
A leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics.
Orion Genomics provides genomics research services and clinical laboratory services to leading healthcare and agricultural research organizations.
We develop specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.
TGen, the Translational Genomics Research Institute, is an affiliate of City of Hope. We are an Arizona-based, nonprofit medical research institute dedicated to conducting groundbreaking research with life-changing results.
Transnetyx is the trusted automated genotyping resource for thousands of researchers in universities, hospitals, and bioscience companies around the world.
Your source for the production of high-volume recombinant therapeutic proteins in the white of transgenic chicken eggs.
We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.
Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!
Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.